The injection is for use in adult patients undergoing diagnostic or therapeutic procedures.
Read Eisai’s press release about the Lusedra approval.
FDA Approves Lusedra Injection for Monitored Anesthesia Care Sedation
Eisai Corp. has announced that the FDA has approved its Lusedra (fospropofol disodium) Injection, an intravenous sedative-hypnotic agent for monitored anesthesia care sedation.
